TABLE 2.

Patient Characteristics

Patient no.Age (y)SexHistologyGradeUICC (initial)Date of initial diagnosisTumor sites on imaging (primary and metastatic)SUVmax
68Ga-FAPI-4618F-FDG
158MiCC3II01/2020Bone, lymph node14.36.3
279FiCC3IIIA01/2021Liver17.55.1
345MpCC2IIIC08/2020Liver14.58.0
444MiCC3II07/2016Liver28.65.2
557FdCC3IIIB03/2018Ductus hepaticus communis, peritoneal11.411.6
670MpCC2II12/2019Liver, lymph node9.34.0
740FiCC2IV04/2021Liver, peritoneal, lymph node25.4NA
879FdCC2IIB03/2019NoneNANA
954FiCC2IIIA03/2021Lymph node9.812.6
1065FiCC2IIIB08/2020Lymph node7.79.2
  • UICC = Union for International Cancer Control; iCC = intrahepatic cholangiocarcinoma; pCC = perihilar cholangiocarcinoma; dCC = distal cholangiocarcinoma; NA = not available.

  • SUVmax was determined in hottest lesion for each tracer.